Hansson O - Search Results

1

Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.

Palmqvist S, Insel PS, Stomrud E, Janelidze S, Zetterberg H, Brix B, Eichenlaub U, Dage JL, Chai X, Blennow K, Mattsson N, Hansson O. Palmqvist S, et al. Among authors: hansson o. EMBO Mol Med. 2019 Dec;11(12):e11170. doi: 10.15252/emmm.201911170. Epub 2019 Nov 11. EMBO Mol Med. 2019. PMID: 31709776 Free PMC article.

2

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

3

Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.

Simonsen AH, McGuire J, Hansson O, Zetterberg H, Podust VN, Davies HA, Waldemar G, Minthon L, Blennow K. Simonsen AH, et al. Among authors: hansson o. Arch Neurol. 2007 Mar;64(3):366-70. doi: 10.1001/archneur.64.3.366. Arch Neurol. 2007. PMID: 17353378

4

Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.

Hansson O, Zetterberg H, Buchhave P, Andreasson U, Londos E, Minthon L, Blennow K. Hansson O, et al. Dement Geriatr Cogn Disord. 2007;23(5):316-20. doi: 10.1159/000100926. Epub 2007 Mar 19. Dement Geriatr Cogn Disord. 2007. PMID: 17374949

5

Kinesin gene variability may affect tau phosphorylation in early Alzheimer's disease.

Andersson ME, Sjölander A, Andreasen N, Minthon L, Hansson O, Bogdanovic N, Jern C, Jood K, Wallin A, Blennow K, Zetterberg H. Andersson ME, et al. Among authors: hansson o. Int J Mol Med. 2007 Aug;20(2):233-9. Int J Mol Med. 2007. PMID: 17611642

6

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

Stomrud E, Hansson O, Blennow K, Minthon L, Londos E. Stomrud E, et al. Among authors: hansson o. Dement Geriatr Cogn Disord. 2007;24(2):118-24. doi: 10.1159/000105017. Epub 2007 Jul 2. Dement Geriatr Cogn Disord. 2007. PMID: 17622715

7

Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease.

Hansson O, Buchhave P, Zetterberg H, Blennow K, Minthon L, Warkentin S. Hansson O, et al. Neurobiol Aging. 2009 Feb;30(2):165-73. doi: 10.1016/j.neurobiolaging.2007.06.009. Epub 2007 Jul 23. Neurobiol Aging. 2009. PMID: 17646035

8

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

Boström F, Hansson O, Gerhardsson L, Lundh T, Minthon L, Stomrud E, Zetterberg H, Londos E. Boström F, et al. Among authors: hansson o. Neurobiol Aging. 2009 Aug;30(8):1265-71. doi: 10.1016/j.neurobiolaging.2007.10.018. Epub 2008 Jan 8. Neurobiol Aging. 2009. PMID: 18191875

9

Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.

Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J. Höglund K, et al. Among authors: hansson o. Neurodegener Dis. 2008;5(5):268-76. doi: 10.1159/000119457. Epub 2008 Feb 29. Neurodegener Dis. 2008. PMID: 18309230

10

Slowing of EEG correlates with CSF biomarkers and reduced cognitive speed in elderly with normal cognition over 4 years.

Stomrud E, Hansson O, Minthon L, Blennow K, Rosén I, Londos E. Stomrud E, et al. Among authors: hansson o. Neurobiol Aging. 2010 Feb;31(2):215-23. doi: 10.1016/j.neurobiolaging.2008.03.025. Neurobiol Aging. 2010. PMID: 18462837

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

822 results

Search Page

Filters